Interparfums
IPAR
#4018
Rank
HK$22.83 B
Marketcap
HK$712.09
Share price
0.44%
Change (1 day)
-19.16%
Change (1 year)

Interparfums - 10-Q quarterly report FY


Text size:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-Q

(MARK ONE)

/X/ Quarterly Report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the quarterly period ended June 30, 2001.

OR

/_/ Transition Report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from ___________to
________.


Commission File No. 0-16469

INTER PARFUMS, INC.
(Exact name of registrant as specified in its charter)

DELAWARE 13-3275609
--------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)

551 FIFTH AVENUE, NEW YORK, NEW YORK 10176
----------------------------------------------
(Address of Principal Executive Offices) (Zip Code)

(212) 983-2640
--------------------------------------------
(Registrants telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days: Yes X No

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

At August 6, 2001 there were 11,630,777 shares of common stock, par value $.001
per share, outstanding.
INTER PARFUMS, INC. AND SUBSIDIARIES

INDEX


Page Number

Part I. Financial Information

Item 1. Financial Statements 1

Consolidated Balance Sheets as
of June 30, 2001 (unaudited)
and December 31, 2000 (audited) 2

Consolidated Statements of
Income for the Three and Six Months
Ended June 30, 2001 (unaudited)
and June 30, 2000 (unaudited) 3

Consolidated Statements of
Cash Flows for the
Six Months Ended
June 30, 2001 (unaudited) and
June 30, 2000 (unaudited) 4

Notes to Unaudited Financial
Statements 5

Item 2. Management's Discussion and
Analysis of Financial Condition
and Results of Operations 7

Item 3. Quantitative and Qualitative Disclosures
About Market Risk 11

Part II. Other Information 13

Item 3. Changes in Securities and Use of Proceeds 13

Item 5. Other information 14

Signatures 14
INTER PARFUMS, INC. AND SUBSIDIARIES


PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

In the opinion of management, the accompanying unaudited consolidated
condensed financial statements contain all adjustments (consisting only of
normal recurring adjustments) necessary to present fairly the financial position
of the Company and its results of operations and cash flows for the interim
periods presented. Such financial statements have been condensed in accordance
with the rules and regulations of the Securities and Exchange Commission and
therefore, do not include all disclosures required by generally accepted
accounting principles. These financial statements should be read in conjunction
with the Company's audited financial statements for the year ended December 31,
2000 included in the Company's annual report filed on Form 10-K.

The results of operations for the six months ended June 30, 2001 are
not necessarily indicative of the results to be expected for the entire fiscal
year.



Page 1
INTER PARFUMS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS


ASSETS

June 30, December 31,
2001 2000
------------ ------------

CURRENT ASSETS:
Cash and cash equivalents $ 28,782,777 $ 27,598,771
Accounts receivable, net 28,871,534 30,844,146
Inventories 30,265,836 25,340,440
Receivables, other 1,223,215 496,663
Other 1,146,393 1,807,680
Deferred tax benefit 487,842 435,211
------------ ------------

Total current assets 90,777,597 86,522,911

EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET 3,145,750 3,162,177

OTHER ASSETS 290,768 347,324

INTANGIBLE ASSETS, NET 3,942,548 4,538,663
------------ ------------

$ 98,156,663 $ 94,571,075
============ ============


LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
Loans payable, banks $ 5,608,518 $ 2,542,286
Accounts payable 16,814,454 18,223,812
Accrued expenses 8,883,923 6,961,322
Income taxes payable 501,459 1,107,968

------------ ------------

Total current liabilities 31,808,354 28,835,388
------------ ------------

DEFERRED TAXES PAYABLE 623,516 684,304
------------ ------------

LONG-TERM DEBT, LESS CURRENT PORTION 1,319,050 1,416,631
------------ ------------

MINORITY INTERESTS 8,583,634 8,573,594
------------ ------------

SHAREHOLDERS' EQUITY:
Common stock, $.001 par; authorized
30,000,000 shares; outstanding 11,630,777
and 11,676,277 shares at June 30, 2001 and
December 31, 2000, respectively 11,631 11,676
Additional paid-in capital 27,729,177 27,729,177
Retained earnings 62,640,275 58,667,619
Accumulated other comprehensive income (9,374,922) (6,573,513)
Treasury stock, at cost, 5,781,905 and
5,736,405 shares at June 30, 2001 and
December 31, 2000, respectively (25,184,052) (24,773,801)
------------ ------------

55,822,109 55,061,158
------------ ------------

$ 98,156,663 $ 94,571,075
============ ============


SEE NOTES TO FINANCIAL STATEMENTS.

Page 2
INTER PARFUMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME

<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
2001 2000 2001 2000
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
NET SALES $26,259,763 $24,277,090 $57,302,939 $46,445,604

COST OF SALES 13,701,340 12,540,957 29,130,397 24,785,777
----------- ----------- ----------- -----------

GROSS MARGIN 12,558,423 11,736,133 28,172,542 21,659,827

SELLING, GENERAL AND ADMINISTRATIVE 9,232,698 9,199,843 21,102,392 16,665,935
LITIGATION EXPENSE 556,043 556,043
----------- ----------- ----------- -----------

INCOME FROM OPERATIONS 3,325,725 1,980,247 7,070,150 4,437,849
----------- ----------- ----------- -----------

OTHER CHARGES (INCOME):
Interest 80,063 104,481 129,675 162,386
(Gain) loss on foreign currency (228,353) (18,671) (176,277) 20,486
Interest and dividend (income) (368,782) (283,794) (651,319) (511,782)
Loss on sale of stock of subsidiary, net 85,805 10,243 85,805 10,243
Realized (gain) on sale of investments (1,077,110) (1,577,261)
----------- ----------- ----------- -----------

(431,267) (1,264,851) (612,116) (1,895,928)
----------- ----------- ----------- -----------

INCOME BEFORE INCOME TAXES 3,756,992 3,245,098 7,682,266 6,333,777

INCOME TAXES 1,409,509 1,393,220 2,863,922 2,806,549
----------- ----------- ----------- -----------

NET INCOME BEFORE MINORITY INTEREST 2,347,483 1,851,878 4,818,344 3,527,228

MINORITY INTEREST IN NET INCOME
OF CONSOLIDATED SUBSIDIARY 406,280 344,003 845,689 597,015
----------- ----------- ----------- -----------

NET INCOME $1,941,203 $1,507,875 $3,972,655 $2,930,213
=========== =========== =========== ===========

NET INCOME PER COMMON SHARE:
BASIC $0.17 $0.13 $0.34 $0.25
DILUTED $0.15 $0.12 $0.30 $0.23
=========== =========== =========== ===========

NUMBER OF COMMON SHARES OUTSTANDING:
BASIC 11,630,777 11,754,490 11,631,394 11,760,787
DILUTED 13,323,348 13,026,453 13,208,319 12,975,711
============ ============ ============ ============
</TABLE>

SEE NOTES TO FINANCIAL STATEMENTS.

Page 3
INTER PARFUMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

Six months ended
June 30,
2001 2000
----------- -----------

OPERATING ACTIVITIES:
Net income $3,972,656 $2,930,213
Adjustments to reconcile net income to
net cash provided by operating activities:
Depreciation and amortization 935,766 1,019,675
Realized (gain) on sale of
marketable securities (1,577,261)
Loss on sale of stock of subsidiary 85,805 10,243
Minority interest in net income 845,689 597,015
Increase (decrease) in cash from changes in:
Accounts receivable (197,517) (1,263,368)
Inventories (7,036,993) (8,659,074)
Other assets (162,283) (812,136)
Accounts payable and accrued expenses 2,412,213 4,769,727
Income taxes payable (623,455) (129,377)
----------- -----------

Net cash provided by (used in)
operating activites 231,880 (3,114,343)
----------- -----------

INVESTING ACTIVITIES:
Purchase of equipment and leasehold
improvements (818,245) (1,001,751)
Trademark and license acquisitions (950)
Purchase of marketable securities (1,895,083)
Proceeds from sale of marketable securities 4,992,684
----------- -----------

Net cash provided by (used in)
investing activities (818,245) 2,094,900
----------- -----------

FINANCING ACTIVITIES:
Increase in loan payable, bank 3,463,811 2,450,337
Proceeds from sale of stock of subsidiary 106,535 27,802
Proceeds from exercise of stock options 136,250
Dividends paid (197,144) (134,543)
Purchases of treasury stock (410,296) (800,392)
----------- -----------

Net cash provided by financing
activities 2,962,906 1,679,454
----------- -----------

EFFECT OF EXCHANGE RATE CHANGES ON CASH (1,192,535) (579,384)
----------- -----------

INCREASE IN CASH AND CASH EQUIVALENTS 1,184,006 80,627

Cash and cash equivalents at beginning
of period 27,598,771 24,936,361
----------- -----------

CASH AND CASH EQUIVALENTS AT END OF PERIOD $28,782,777 $25,016,988
=========== ===========


SUPPLEMENTAL DISCLOSURE OF CASH FLOWS
INFORMATION:

Cash paid during the period for:
Interest $105,000 $197,000
Income taxes 2,547,000 2,262,000



SEE NOTES TO FINANCIAL STATEMENTS.

Page 4
INTER PARFUMS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED FINANCIAL STATEMENTS

1. SIGNIFICANT ACCOUNTING POLICIES:

The accounting policies followed by the Company are set forth in the notes
to the Company's financial statements included in its Form 10-K which was
filed with the Securities and Exchange Commission for the year ended
December 31, 2000.

2. COMPREHENSIVE INCOME:

Six months Six months
ended ended
June 30, 2001 June 30, 2000
------------- -------------
Comprehensive income:
Net income $ 3,972,655 $ 2,930,213
Other comprehensive income, net of tax:
Foreign currency
translation adjustment (2,742,039) (1,383,951)
Cumulative effect of adopting SFAS 133
as of January 1, 2001 274,201
Gains on derivatives reclassified
into earnings (274,201)
Change in fair value of derivatives (59,370)
Unrealized gains on securities:
Unrealized holding gains arising
during period 347,954
Less: reclassification adjustment for
gains realized in net income (728,694)
----------- -----------

Comprehensive income $ 1,171,246 $ 1,165,522
=========== ===========


3. GEOGRAPHIC AREAS:

Segment information related to domestic and foreign operations is as
follows:

Six months Six months
ended ended
June 30, 2001 June 30, 2000
------------- -------------
Net sales:
United States $15,837,931 $15,362,350
Europe 41,535,008 31,143,254
Eliminations (70,000) (60,000)
----------- -----------
$57,302,939 $46,445,604
=========== ============
Net Income:
United States $ 1,078,916 $ 840,258
Europe 2,893,739 2,094,088
South America (0) (4,133)
----------- -----------
$ 3,972,655 $ 2,930,213
=========== ===========
Page 5
INTER PARFUMS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED FINANCIAL STATEMENTS


4. EARNINGS PER SHARE:

Basic earnings per share are computed using the weighted average number of
shares outstanding during each period. Diluted earnings per share are
computed using the weighted average number of shares outstanding during
each period, plus the incremental shares outstanding assuming the exercise
of dilutive stock options.

5. INVENTORIES:

Inventories consist of the following:

JUNE 30, DECEMBER 31,
2001 2000

Raw materials and component parts $10,135,641 $ 8,775,558
Finished goods 20,130,195 16,564,882
----------- -----------
$30,265,836 $25,340,440
=========== ===========


6. RECENT ACCOUNTING DEVELOPMENTS:

The Financial Accounting Standards Board issued Statement of Financial
Accounting Standards ("SFAS") No. 133, Accounting for Derivative
Instruments and Hedging Activities. SFAS No. 133, as amended, is effective
for all quarters of fiscal years beginning after June 15, 2000 and does not
permit retroactive restatement of prior period financial statements. This
statement requires the recognition of all derivative instruments as either
assets or liabilities in the balance sheet measured at fair value.
Generally, increases or decreases in fair value of derivative instruments
will be recognized as gains or losses in earnings in the period of change.
If the derivative is designated and qualifies as a cash flow hedge, the
changes in fair value of the derivative instrument will be recorded in
other comprehensive income.

We periodically enter into foreign currency forward exchange contracts to
hedge exposure related to receivables denominated in a foreign currency and
to manage risks related to future sales expected to be denominated in a
foreign currency. Before entering into a derivative transaction for hedging
purposes, we determine that a high degree of initial effectiveness exists
between the change in the value of the hedged item and the change in the
value of the derivative from a movement in foreign currency rates. High
effectiveness means that the change in the value of the derivative will
effectively offset the change in the fair value of the hedged item. We
measure the effectiveness of each hedge throughout the hedged period. Any
hedge ineffectiveness as defined by SFAS No. 133 is recognized in the
income statement.

On January 1, 2001 we adopted SFAS No. 133. The transition adjustment for
derivatives in cash flow hedges was to record an asset in the amount of
$274,000 and was recognized as a cumulative-effect-type adjustment in
accumulated other comprehensive income.

Page 6
INTER PARFUMS, INC. AND SUBSIDIARIES


ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF
OPERATIONS

We are a leading manufacturer and distributor of fragrances, cosmetics and
personal care products. Innovation and creativity are combined to produce
quality products for our customers around the world.

We operate in the fragrance and cosmetic industry, specializing in prestige
fragrances and mass market fragrances and cosmetics:

X Prestige products -- For each prestige brand, owned or licensed by us, we
create an original concept for the perfume consistent with world market
trends;

X Mass market products -- We design, market and distribute inexpensive
fragrances and personal care products including alternative designer
fragrances, health and beauty aids and mass market cosmetics.

Statements in this document, which are not historical in nature, are
forward-looking statements. Forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual results to be
materially different from projected results. Given these risks, uncertainties
and other factors, persons are cautioned not to place undue reliance on the
forward-looking statements.

Such factors include effectiveness of sales and marketing efforts and product
acceptance by consumers, dependence upon management, competition, currency
fluctuation and international tariff and trade barriers, governmental regulation
and possible liability for improper comparative advertising or "Trade Dress".

THREE AND SIX MONTHS ENDED JUNE 30, 2001 AS COMPARED TO
THE THREE AND SIX MONTHS ENDED JUNE 30, 2000

Net sales for the three months ended June 30, 2001 increased 8% to $26.3
million, as compared to $24.3 million for the corresponding period of the prior
year. At comparable foreign currency exchange rates, net sales increased 14% for
the period.

Net sales for the six months ended June 30, 2001 increased 23% to $57.3 million,
as compared to $46.4 million for the corresponding period of the prior year. At
comparable foreign currency exchange rates, net sales increased 29% for the
period.

Page 7
INTER PARFUMS, INC. AND SUBSIDIARIES


The increase in net sales represents the seventh consecutive quarter of revenue
growth and is attributable to across-the-board increases in both our prestige
and mass market product lines. The precipitous rise of the US dollar in relation
to the French franc continues to mask our real revenue growth rate.

The constant dollar net sales growth rate for our prestige products was 16% and
42% for the three and six month periods ended June 30, 2001, respectively. This
achievement is the result of the continued success of our PAUL SMITH and
BURBERRY TOUCH fragrance lines, which debuted in the second half of 2000. Our
new Christian Lacroix EAU FLORALE, which was introduced in the first quarter
2001, shares some of the credit for our revenue gains.

In addition to expanding the geographic distribution of products launched in
2000, we have new prestige product launches scheduled to roll out during 2001.
We are leveraging the popularity of "Burberry Touch" by bringing to market a new
bath line for men and women, which began shipping in late June 2001.
Additionally, we are on target for the initial launch of two new Celine
fragrances in the fourth quarter of 2001. Celine, a division of LVMH Moet
Hennessy Louis Vuitton S.A., is a French fashion and accessory company known
throughout the world for its luxury and quality products, as well as the unique
designs of Michael Kors.

Our FUBU fragrance line is also under development and is expected to debut at
select men's and ladies specialty stores in January 2002. Full department store
and international distribution is planned for the second quarter of 2002. FUBU,
founded in 1992, has exploded onto the young men's fashion scene. Music, movie,
television and sport stars have worn the designs recognizable by the FUBU logos.
Today, FUBU product sales exceed $350 million, and encompass men's
sportswear-formalwear, ladies, and children's apparel, as well as footwear and
accessory items.

Net sales of our mass market products, were up 8% for the three months ended
June 30, 2001, as compared to the corresponding period of the prior year. This
is the result of the recent launch of our new line of health and beauty aids
("HBA"), which are being sold under our Intimate brand name. Further HBA line
expansion is planned throughout 2001. Sales generated from our mass market
fragrance lines have recently shown some weakness; however, our Aziza cosmetic
line, which was launched in the first quarter of 2000, continues to perform very
well. Additional Aziza product line extensions are in progress.

Growing sales within existing product lines, new product launches and an active
new business development program are how we plan to continue to grow our
business. With respect to new business development, several licensing and
acquisition opportunities are presently under discussion. However, we cannot
assure you that any such transactions will be completed.

Page 8
INTER PARFUMS, INC. AND SUBSIDIARIES


Gross profit margin was 48% and 49% of net sales for the three and six month
periods ended June 30, 2001, respectively, as compared to 48% and 47% for the
corresponding periods of the prior year. Our target gross margin percentage has
historically been 45% to 46%. However, gross profit margins have increased
recently as a result of the strength of the US dollar in relation to the Euro,
as certain European sales are denominated in US dollars. In addition, our
prestige fragrance lines, which have been growing at a faster rate than our mass
market lines, generate a higher gross profit margin than our mass market product
lines.

Selling, general and administrative expenses aggregated $9.2 million for both
three month periods ended June 30, 2001 and June 30, 2000. As a percentage of
sales, selling, general and administrative expenses declined to 35% of sales for
the three months ended June 30, 2001, as compared to 38% for the corresponding
period of the prior year. Selling, general and administrative expenses
aggregated $21.1 million for the six months ended June 30, 2001, as compared to
$16.7 million for the corresponding period of the prior year. As a percentage of
sales, selling, general and administrative expenses was 37% for the six months
ended June 30, 2001, as compared to 36% for the corresponding period of the
prior year.

Promotion and advertising are prerequisites for sales of designer products. We
develop a complete marketing and promotional plan to support our growing
portfolio of prestige fragrance brands and to build upon each brand's awareness.
We typically budget advertising and promotion expenditures based upon sales of
each of our product lines. As a result of the success of the Burberry Touch and
Paul Smith launches in late 2000, we increased advertising and promotional
activities in early 2001 to keep the momentum of the second half of 2000 going.
With no major launches occurring during the three month period ended June 30,
2001, fixed expenses were spread over a higher sales base.

As previously reported, our French subsidiary, Inter Parfums, S.A., is a party
to litigation with Jean Charles Brosseau, S.A. ("Brosseau"), the licensor of the
Ombre Rose trademark. In October 1999, Inter Parfums, S.A. received notice of a
judgment in favor of Brosseau, which awarded damages of approximately $600,000
and which directed Inter Parfums, S.A. to turn over its license to Brosseau
within six months.

Inter Parfums, S.A. is appealing the judgment as it vigorously and categorically
denies the claims of Brosseau. In June 2000, as a result of certain
developments, Inter Parfums, S.A. and its special litigation counsel considered
it likely that the judgment would be sustained and therefore took a charge
against earnings for $600,000, the full amount of the judgment. In February
2001, the Court of Appeal confirmed the Brosseau claim with respect to turning
over the license. In addition, the Court named an expert to proceed with
additional investigations and required Inter Parfums, S.A. to pay $142,000 as an
advance for damages claimed by Brosseau.

Page 9
INTER PARFUMS, INC. AND SUBSIDIARIES


Inter Parfums, S.A. is continuing its appeal as it still denies the claims of
Brosseau. Management does not believe that such litigation will have any further
material adverse effect on the financial condition or operations of the Company.

During the three month period ended June 30, 2000 we sold a portion of our
investment in marketable securities and realized a gain of $1.1 million
($500,000 after taxes and minority interest). For the six month period ended
June 30, 2000 such gain aggregated $1.6 million ($700,000 after taxes and
minority interest). On occasion, we invest excess cash in marketable securities
which are classified as available-for-sale. These funds are available to support
current operations or to take advantage of other investment opportunities. There
were no marketable security transactions in 2001.

Our effective income tax rate was 38% for the three months ended June 30, 2001,
as compared to 43% for the corresponding period of the prior year. Our effective
income tax rate was 37% for the six months ended June 30, 2001, as compared to
44% for the corresponding period of the prior year. The effective tax rate for
the three and six month periods ended June 30, 2000 includes a $150,000
($115,000 after minority interest) and $480,000 ($370,000 after minority
interest), respectively, accrual to cover the potential exposure related to a
tax audit of Inter Parfums, S.A. commenced by the French Tax Authorities.

Net income increased 29% to $1.9 million for the three months ended June 30,
2001, as compared to $1.5 million for the corresponding period of the prior
year. Net income for the three months ended June 30, 2000 includes charges of
$375,000 and a gain of $495,000, all after taxes and minority interest. The
charges represent an accrual for exposure relating to the Brosseau litigation of
$260,000 and a potential tax assessment of $115,000. The gain represents a
realized gain on sale of marketable securities.

Net income increased 36% to $4.0 million for the six months ended June 30, 2001,
as compared to $2.9 million for the corresponding period of the prior year. Net
income for the six months ended June 30, 2000 includes charges of $630,000 and a
gain of $725,000, all after taxes and minority interest. The charges represent
an accrual for exposure relating to the Brosseau litigation of $260,000 and a
potential tax assessment of $370,000. The gain represents a realized gain on
sale of marketable securities.

Diluted earnings per share increased 25% to $0.15 for the three months ended
June 30, 2001, as compared to $0.12 for the corresponding period of the prior
year. Diluted earnings per share increased 30% to $0.30 for the six months ended
June 30, 2001, as compared to $0.23 for the corresponding period of the prior
year.

Page 10
INTER PARFUMS, INC. AND SUBSIDIARIES


Weighted average shares outstanding aggregated 11.6 million for both the three
and six month periods ended June 30, 2001, as compared to 11.8 million for both
the three and six month periods ended June 30, 2000. On a diluted basis, average
shares outstanding were 13.3 million and 13.2 million for the three and six
month periods ended June 30, 2001, respectively, as compared to 13.0 million for
both the three and six month periods ended June 30, 2000.
The increase in the market price of our common stock has increased the dilutive
effect of outstanding stock options, thereby increasing diluted shares
outstanding. This was partially offset by shares repurchased pursuant to our
stock repurchase program.


LIQUIDITY AND CAPITAL RESOURCES

Our financial position remains very strong as a result of continued profitable
operating results. At June 30, 2001, working capital aggregated $59 million and
we had a working capital ratio of almost 3 to 1. Cash and cash equivalents
aggregated $29 million and our net book value was $4.80 per outstanding share as
of June 30, 2001. Furthermore, we had only $1.3 million in long-term debt.

On occasion we use a portion of our cash to make investments in marketable
equity securities, which are classified as available-for-sale. These funds are
available to support current operations or to take advantage of other investment
opportunities. These investments are made to maximize our return on cash. During
2001, we made no investments in marketable equity securities and have no
positions presently outstanding.

Our short-term financing requirements are expected to be met by available cash
at June 30, 2001, cash generated by operations and short-term credit lines
provided by domestic and foreign banks. The principal credit facilities for 2001
are a $12.0 million unsecured revolving line of credit provided by a domestic
commercial bank and approximately $12.0 million in credit lines provided by a
consortium of international financial institutions.

Cash provided by operating activities aggregated $0.2 million for the six months
ended June 30, 2001 as compared to a use of $3.1 million for the corresponding
period of the prior year. In addition to increased earnings, favorable payment
terms from our vendors helped us generate cash from operations while we build up
our inventory levels in anticipation of net sales growth. Cash provided by
operating activities continues to be the primary source of funds to finance
operating needs and investments in new ventures.

We believe that funds generated from operations, supplemented by our present
cash position and available credit facilities, will provide us with sufficient
resources to meet all present and reasonably foreseeable future operating needs.

Page 11
INTER PARFUMS, INC. AND SUBSIDIARIES


In January 1999, certain member countries of the European Union established
permanent fixed rates between their existing currencies and the European Union's
common currency ("the Euro"). The transition period for the introduction of the
Euro is scheduled to phase in over a period ending January 1, 2002. The
introduction of the Euro and the phasing out of the other currencies should not
have a material impact on our consolidated financial statements.

Inflation rates in the U.S. and foreign countries in which we operate have not
had a significant impact on operating results for the six months ended June 30,
2001.


ITEM 3: QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK

GENERAL

We address certain financial exposures through a controlled program of risk
management that primarily consists of the use of derivative financial
instruments. We primarily enter into foreign currency forward exchange contracts
in order to reduce the effects of fluctuating foreign currency exchange rates.
We have entered into one (1) interest rate swap in an attempt to take advantage
of low variable interest rates as compared to the fixed rate on our long-term
debt. We do not engage in the trading of foreign currency forward exchange
contracts or interest rate swaps.

FOREIGN EXCHANGE RISK MANAGEMENT

We enter into forward exchange contracts to hedge receivables denominated in
foreign currencies for periods consistent with our identified exposures. The
purpose of the hedging activities is to minimize the effect of foreign exchange
rate movements on the receivables and cash flows of Inter Parfums, S.A., our
French subsidiary, whose functional currency is French francs. All foreign
currency contracts are denominated in currencies of MAJOR industrial countries
and are with large financial institutions, which are rated as strong investment
grade. Gains and losses related to qualifying hedges of these exposures are
deferred and recognized in operating income when the underlying hedged
transaction occurs.

We believe that our risk of loss as the result of nonperformance by any of such
financial institutions is remote and in any event would not be material. The
contracts have varying maturities with none exceeding one year. Costs associated
with entering into such contracts have not been material to our financial
results. At June 30, 2001, we had foreign currency contracts in the form of
forward exchange contracts in the amount of approximately $4.5 million. The
foreign currencies included in these contracts are principally the U.S. dollar.

Page 12
INTER PARFUMS, INC. AND SUBSIDIARIES


INTEREST RATE RISK MANAGEMENT

We mitigate interest rate risk by continually monitoring interest rates, and
then determining whether fixed interest rates should be swapped for floating
rate debt, or if floating rate debt should be swapped for fixed rate debt. We
have entered into one (1) interest rate swap to take advantage of declining
interest rates. At June 30, 2001 we had one (1) interest rate swap agreement
outstanding to convert $1.3 million of principal fixed rate debt with an
interest rate of 4.56% to floating interest rate debt, at the EURIBOR rate, over
the life of our long-term debt due in 2004. At June 30, 2001, the EURIBOR rate
was 4.9%. If interest rates were to rise 1% per annum over the remaining term of
the long-term debt, then we would incur a loss of $50,000.


PART II. OTHER INFORMATION


Items 1, 3, 4, and 6 are omitted as they are either not applicable or have
been included in Part I.


ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

The following sets forth certain information as to all options granted to
purchase common stock during the six months ended June 30, 2001, which were not
registered under the Securities Act. In each of the three transactions, we
granted options to affiliates (executive officers and directors), and one
consultant. The transactions were exempt from the registration requirements of
Section 5 of the Securities Act under Sections 4(2) and 4(6) of the Securities
Act. Each option holder agreed that, if the option is exercised, the option
holder would purchase his common stock for investment and not for resale to the
public. The options are not transferable, except to the limited extent permitted
in the option plans.

On February 1, 2001, we granted options to purchase an aggregate of 9,000 shares
for a five year period at the exercise price of $9.75 per share, the fair market
value at the time of grant, to six directors under our 1999 Non-Employee
Director Stock Option Plan.

On March 28, 2001, we granted options to purchase an aggregate of 15,000 shares
for a five year period, 10,000 which vests immediately at the exercise price of
$10.375 per share, the fair market value at the time of grant, and 5,000, which
vests upon the satisfaction of a contingency, at the exercise price equal to the
fair market value upon the satisfaction of such contingency, to one consultant
under our 1999 Stock Option Plan.

Page 13
INTER PARFUMS, INC. AND SUBSIDIARIES


On April 3, 2001, we granted an option to purchase 5,000 shares for a five year
period at the exercise price of $10.625 per share, the fair market value at the
time of grant, to one executive officer under our 1999 Stock Option Plan.


ITEM 5. OTHER INFORMATION

Our Board of Directors has approved a three-for two stock split (in the
form of a 50% stock dividend), payable on September 14, 2001 to shareholders of
record as of the close of business on August 31, 2001. Fractional shares will be
rounded up to the nearest whole share.








SIGNATURES
----------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized on the 8th day of August 2001.


INTER PARFUMS, INC.


By: /s/ RUSSELL GREENBERG
------------------------------------
Executive Vice President and
Chief Financial Officer



Page 14